Clarix Imaging is a medical technology company committed to advancing the standard of care in cancer surgery, particularly for lumpectomy procedures. Their core innovation, the VSI-360™, is an FDA-cleared and CE-marked volumetric specimen imager. This system provides surgeons with real-time, three-dimensional visualization of excised tissue and tumor margins directly within the operating room. The primary goal of this technology is to significantly reduce the incidence of positive margins, thereby minimizing the need for re-excision surgeries and improving patient outcomes in breast-conserving surgery and other cancer treatments.
The Chicago headquarters serves as the nerve center for Clarix Imaging, housing its primary research and development activities, corporate administration, manufacturing liaison, and strategic business operations.
The headquarters is uniquely located within 'The Plant,' a historic former meatpacking facility that has been innovatively repurposed into a dynamic, sustainable business incubator focused on food production and other green enterprises. This provides a distinctive and inspiring environment.
The work culture at Clarix Imaging is characterized by a strong sense of mission, innovation, and collaboration. Being at the forefront of medical device technology and located in a unique, repurposed industrial space encourages a creative, problem-solving, and results-oriented atmosphere focused on patient impact.
Chicago provides access to a rich talent pool, world-class research institutions, and a vibrant healthcare ecosystem, making it a strategic location. The unique setting of 'The Plant' also underscores a commitment to innovation and sustainability.
Clarix Imaging is expanding its global reach, primarily focusing on North America and Europe. With FDA clearance in the United States and CE marking for European markets, the company actively supports clinical adoption, sales, distribution, and post-market surveillance for its VSI-360™ system. Their efforts are geared towards making their advanced intraoperative imaging technology accessible to surgical teams worldwide to improve cancer treatment outcomes.
3622 S. Morgan Street
Chicago
IL
USA
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Clarix Imaging' leadership includes:
Clarix Imaging has been backed by several prominent investors over the years, including:
Based on publicly available information, there have been no major executive new hires or departures announced by Clarix Imaging in the last 12 months. The leadership team appears stable as the company focuses on commercialization and market expansion.
Discover the tools Clarix Imaging uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Clarix Imaging commonly uses the email format of the employee's first name, followed by a period, and then their last name, all preceding '@clariximaging.com'. Other formats may exist but this is the most frequently observed.
[first].[last]@clariximaging.com
Format
xiao.han@clariximaging.com
Example
85%
Success rate
Business Wire • April 10, 2024
Clarix Imaging announced its participation and showcase of the VSI-360™, its innovative intraoperative 3D specimen imaging system, at the American Society of Breast Surgeons (ASBrS) 25th Annual Meeting. The technology is designed to help surgeons achieve clear margins during lumpectomy procedures....more
PR Newswire • February 7, 2023
Clarix Imaging successfully closed a $5 million Series A financing round. Key investors included OCA Ventures, Serra Ventures, W Capital, Illinois Ventures, IrishAngels, and Suncoast Angels. These funds are designated to accelerate the commercialization of the VSI-360 imaging system....more
PR Newswire • October 5, 2021
Clarix Imaging obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its VSI-360™ system. This clearance allows for the marketing and sale of the volumetric specimen imager for use in intraoperative margin assessment during breast cancer surgery in the United States....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Clarix Imaging, are just a search away.